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Background: An emerging field of research describes the role of preoperative health behaviours, known as
prehabilitation. The preoperative period may be a more physically and emotionally salient time to introduce and
foster chronic adherence to health behaviours, such as exercise, in patients compared to post-treatment during
recovery. Moreover, physical and psychosocial improvements during the preoperative period may translate into an
enhanced recovery trajectory with reduced operative complications and postoperative adverse effects. No studies
have assessed prehabilitation for men with prostate cancer undergoing radical prostatectomy.
Methods/Design: This is a multi-centre, pilot randomized control trial conducted at two Canadian urban teaching
hospitals. 100 men undergoing radical prostatectomy for prostate cancer with no contraindications to exercise will
be recruited and randomized to the prehabiliation program or usual care. Prehabilitation participants will engage in
a preoperative, individualized exercise program including pelvic floor muscle strengthening instructions and a
healthy lifestyle guide for men with prostate cancer. These participants will be asked to engage in 60 minutes of
home-based, unsupervised, moderate-intensity exercise on 3–4 days per week. Usual care participants will receive
the same pelvic floor muscle strengthening instructions and healthy lifestyle guide only. We will assess the feasibility
of conducting an adequately powered trial of the same design via recruitment rate, programmatic adherence/
contamination, attrition, and safety. Estimates of intervention efficacy will be captured through measurements at
baseline (4–8 weeks preoperatively), within 1 week prior to surgery, and postoperatively at 4, 12, and 26 weeks.
Efficacy outcomes include: fatigue, quality of life, urinary incontinence, physical fitness, body composition, aerobic
fitness, pain, and physical activity volume.
Discussion: The primary outcome of this study is to determine the feasibility of conducting a full-scale, randomized
controlled trial of prehabilitation versus usual care and to estimate effect sizes that will inform sample size determinations
for subsequent trials in this field. To our knowledge, this is the first study to examine a structured presurgical exercise
program for men undergoing radical prostatectomy for prostate cancer. This trial will advance our understanding of
strategies to efficiently and effectively use the preoperative period to optimize postoperative recovery.
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Radical prostatectomy (RP) is the most common and
effective treatment for localized prostate cancer (PCa),
with a 15-year survival rate of approximately 90% [1,2].
Unfortunately, RP is associated with significant adverse
effects, such as urinary incontinence, sexual dysfunction,
and reduced physical function that collectively diminish
health-related quality of life (HRQOL); such decrements
may persist for up to two years postoperatively [3,4].
Given the efficacy of RP and its widespread use in the man-
agement of PCa, it is suggested that the metric of surgical
success should include more than simply disease-free sur-
vival; rather, it should include a comprehensive assessment
of physical and psychosocial wellbeing and the rate at which
the patient returns to baseline levels of wellbeing [1,5].
Traditionally, interventions intended to improve RP
recovery and minimize adverse effects were limited to
the postoperative period. Such approaches have typically
focused on the urological side effects of urinary incon-
tinence and sexual dysfunction through pelvic floor
muscle exercises (PFMX) and/or phosphodiesterase-5
inhibitors while psychotherapy is commonly employed
for psychological adjustments in the postoperative
period [5-8]. Overall, research suggests that patients are
often non-adherent to the prescribed postoperative
interventions [9]. Furthermore, little attention has been
directed towards the general physical and functional
declines that RP patients experience, despite their
significant contribution to overall HRQOL [10,11]. Stras-
sels et al. [12] found that physical functioning one month
post-RP was below population norms and that 43% were
dissatisfied with their physical ability. At 3 months post-
RP, Litwin et al. [13] found that only 30% and 36% of pa-
tients had returned to baseline values of physical function
and energy levels, respectively. Given that the recovery
from RP may be blunted by postoperative decreases in
physical functioning and concomitant non-compliance
with traditional post-RP treatments, examination of inter-
ventions applied in the pre-surgical phase is warranted.
To enhance the overall surgical experience for patients,
an important question revolves around when the most
opportune time is to introduce recovery-optimizing
behaviours. The postoperative period may be less than
ideal due to concerns related to perturbing the healing
process as patients await additional results or treatments.
Instead, an emerging field of research describes the role of
preoperative strategies to improve treatment tolerance
and recovery. The preoperative period may be more phys-
ically and emotionally salient for patients by capitalizing
on: i) the generally better physical condition of the patient
(compared to the acute postoperative period), ii) surgical
wait-list times, and iii) a ‘teachable moment’ for the
patient that accompanies the need for major surgery [14].
Ultimately, it appears that the preoperative period may bean optimal time to invest into the modifiable factors that
contribute to peri- and postoperative health.
A health behaviour that has demonstrated great promise
in terms of its beneficial relationship with perioperative
complications and postoperative recovery is physical activ-
ity and the consequential improved physical fitness levels.
Studies routinely report that patients who are physically
active and fit recover more quickly, have fewer periopera-
tive complications, and experience better convalescence
compared with patients who are less physically active and
fit [15-21]. Pre-habilitation is defined as the process of
enhancing one’s functional and mental capacity to enable
him/her to withstand a significant stressor [22]. In a surgi-
cal setting, preoperative physical and/or psychological
conditioning aims to increase body and mind reserves to
prevent the declines in postoperative wellbeing [22]. Re-
cently published systematic reviews of prehabilitation have
described numerous benefits to postoperative wellbeing
across a variety of surgical populations [23-25], including
cancer-patients specifically [26]. Carli and colleagues have
shown that prehabilitation can improve postoperative
physical function in cancer patients undergoing colorectal
surgery [27,28], hysterectomy [29], and lung resection
[30]. Their group has also found that improvements in
physical function were associated with improvements in
mental health, vitality, and self-perceived health [31].
Moreover, it appears that control subjects whose fitness
deteriorated preoperatively had more surgical complica-
tions and greater need for intensive care [31].
With respect to PCa patients undergoing RP, we have
previously shown in an observational study that physical ac-
tivity in the year prior to RP is associated with improved
postoperative HRQOL [32]. Additionally, in a cohort of 509
patients undergoing RP, we observed that men who were
meeting physical activity guidelines prior to surgery had
greater HRQOL at 6 and 26 weeks postoperatively com-
pared to men who were not meeting the PA guidelines
[33]. Moreover, we found that men who were active pre-
operatively were less likely to report being incontinent
6 weeks after surgery than their inactive counterparts. Exer-
cises targeted at the pelvic floor have also shown benefit for
RP patients as two studies have demonstrated effectiveness
at improving urinary incontinence by 20% compared to
controls [34,35]. These studies have revealed an important
role for physical activity and fitness in the postoperative
wellbeing of men undergoing RP; however, no randomized
controlled trial has been conducted to determine a causal
relationship between preoperative exercise and postopera-
tive outcomes in this population. Thus, there remains an
important opportunity to examine a comprehensive preha-
bilitation program for men undergoing RP for PCa that
may have a profound influence on surgical preparation by
reducing the often-chronic nature of complete recovery
from this procedure.
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This study is a 2-arm, multi-centre, pilot randomized
controlled trial to examine the effect of a comprehensive
prehabilitation program (PREHAB) versus usual care (UC).
The primary objective of this study is to assess the feasibil-
ity of conducting of an adequately powered study of similar
design. Our secondary objective is to report estimates of
efficacy on several clinically important outcomes for RP
patients.
This study will be conducted at two urban Canadian
teaching hospitals: the Princess Margaret Cancer Centre
in Toronto, Ontario, and the McGill University Health
Centre in Montreal, Quebec. Both participating institutions
have received approval from their respective research
ethics boards.
Participants
We will recruit 100 participants (n = 50 per site and per
group) consistent with recommended sample sizes for a
pilot study [36]. We anticipate an attrition rate of 20%.
Inclusion criteria: Men aged 40 and 80 years of age with
localized PCa (stage cT1- cT2) who have consented for RP
and are proficient in English or French. Exclusion criteria:
i) severe coronary artery disease (Canadian Cardiovascular
Society class III or greater); ii) significant congestive heart
failure (New York Heart Association class III or greater);
iii) uncontrolled pain; iv) neurological or musculoskeletal
co-morbidity inhibiting exercise; v) diagnosed psychotic,
addictive, or major cognitive disorders; vi) no more than
two American College of Sports Medicine Coronary Risk
Factors [37].
Study recruitment and randomization
Eligible patients will be recruited from ambulatory ur-
ology clinics at each site by a research coordinator (RC).
Recruitment posters will also be placed in hospital wait-
ing areas. Written informed consent will be collected
from all patients prior to participation.
Participants will be randomly allocated to either the
PREHAB or UC groups prior to the baseline assessment,
stratified by study site. Blinded allocation of participants
to their treatment groups will be performed via sequen-
tially numbered opaque envelopes that will contain inter-
vention assignments that have been shuffled to create a
random order. Figure 1 provides the structure of partici-
pant flow through each intervention arm.
Study arms
Both groups will begin participation in their respective
study arms at the time of randomization following shortly
after RP scheduling. The duration of the preoperative
wait-time (typically 4-8 weeks) will be recorded. Both
groups will receive a copy of a PCa-specific lifestylesupport book containing information on topics such as
nutrition, active-living, and pelvic floor training [38].
PREHAB
PREHAB participants will engage in an individualized,
total-body exercise and PFMX program. The total-body
exercise prescription will consist of 60 minutes of home-
based, unsupervised exercise on 3–4 days per week. Each
session will be individualized, based upon a baseline
assessment and will include: a 5-minute warm-up,
25 minutes of aerobic exercise (40-60% of heart rate re-
serve; HRR), 25 minutes of resistance training (5 exercises
targeting major muscle groups performed at an intensity of
8–12 repetitions maximum), and a 5-minute cool-down.
Training intensity progression will occur when the partici-
pant can complete aerobic exercise with mild exertion
and/or when the participant can complete 15 repetitions of
a given resistance exercise. Participants will be provided
with varying intensities of resistance bands, a stability ball,
and an exercise mat. The PFMX prescription will begin
with instructions on how to engage the pelvic floor deliv-
ered by the RC trained in PFMX. The PFMX prescription
will include a gradual increase in repetitions from 60 per
day during weeks 1–2, 120 per day during weeks 3–4, and
180 per day during week 5 to the surgical date. The total
number of repetitions of the PFMX will be divided equally
between the rhythmic contractions (contract and relax
over one second) and the sustained contractions (con-
tract and hold for up to 10 seconds). Participants will be
instructed to contract with maximal effort during all
PFMX repetitions. The PREHAB intervention will be sup-
ported with a manual (translated into French) and exercise
videos created by the co-investigating team. The RC will
communicate with the PREHAB participants weekly via
phone or email to ensure program compliance, support
appropriate progression, and address any barriers to exer-
cise that may prevent ongoing participation.
Usual care
RP patients will receive preoperative information from a
urology nurse educator about PFMX, mobilization and
general timeframes for return to normal activities following
RP. The UC group will receive the same PFMX prescrip-
tion as the PREHAB intervention and will receive weekly
communication from the RC regarding compliance with
the PFMX prescription to provide an attentional-control.
Outcome assessments
Self-report measures and physical fitness assessments
will be conducted at: baseline (following RP booking,
prior to beginning group assignment) approximately 4–8
weeks preoperatively, within 1 week prior to RP, and at
4, 12, and 26 weeks postoperatively. All self-reported
measures are available in English and French.
Patient consents to RP
Screen for eligibility
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Figure 1 Participant flow.
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rate (and reasons for non-participation); 2) attrition rate; and
3) adherence and contamination (through a physical activity
log completed by the RC during the weekly communication).
Adherence to the exercise prescription for the PREHAB
intervention and to the PFMX prescription for both groups
will be analyzed by calculating the percentage of total phys-
ical activity volume prescribed (i.e. total number of repeti-
tions completed/total number of repetitions prescribed).
Musculoskeletal fitness will be assessed by grip strength
dynamometry and isometric strength for elbow flexion and
extension by handheld dynamometry. Grip strength will be
measured using a hand grip dynamometer (Sammons
Preston, model Jamar, Bolingbrook, IL, USA) with the par-
ticipant asked to complete two maximal effort squeezes per
hand while standing and arm extended and abducted to 45
degrees [39]. Grip strength will be recorded to the nearest
kilogram, with the maximum value per hand used for out-
come assessment. Isometric strength for elbow flexion and
extension will be measured using a handheld digital dyna-
mometer (Hoggan Health Industries, model Microfet2, UT,
USA) that is positioned on the underside (for flexion) or top-
side (for extension) a table. Participants will be seated with
elbow flexed to 90 degrees, with the dynamometer in hand,
either on the under or topside of table and will gradually
generate force against the dynamometer for 2 seconds, and
then maintains a maximal effort for another 5 seconds. For
elbow flexion, the dynamometer is positioned in the partici-
pant’s hand, with the participant pressing the device upwards,
onto the underside of the table. For elbow extension, the
dynamometer placed in the participant’s hand, with the par-
ticipant pressing the device downwards, onto the topside of
the table. For elbow extension, the dynamometer placed
proximal to wrist on extensor surface of forearm, with the
participant pressing downwards, into the dynamometer. The
participant will complete two trials per arm with the max-
imum value per arm recorded to the nearest kilogram. Waist
circumference (WC) will be measured according to the World
Health Organization protocol, with measuring tape positioned
at the midpoint between lowest rib and iliac crest Body mass
index (BMI, kg/m2) will be calculated using the participant’s
height (m) and weight (kg). Body fat percentage will be
measured through bioelectrical impedance analysis (Tanita
Corporation, model TBF-300A, Tokyo, Japan). Aerobic fitness
will be measured using the 6-Minute Walk Test (6MWT)
[40] that involves the participant walking a 15 meter linear
course for 6 minutes (turning around at each end) with the
total distance traveled recorded. Motivational and time-
remaining cues are standardized to the following:
1:00 – “You’re doing well. You have 5 minutes to go”.
2:00 – “Keep up the good work. You have 4 minutes
to go”.
3:00 – “You’re doing well. You’re halfway done”.4:00 – “Keep you the good work. You have 2 minutes
left”.
5:00 – “You’re doing well. You have only 1 minute
to go”.
5:45 – “In a moment I’m going to tell you to stop.
When I do, just stop right where you are
and I will come to you”.
PCa-specific HRQOL will be measured using the psy-
chometrically validated Functional Assessment of Cancer
Therapy-Prostate (FACT-P) [41] and the Patient-Oriented
Prostate Utility Scale (PORPUS) [42]. Anxiety and depres-
sion will be measured by the Hospital Anxiety and
Depression Scale (HADS) [43]. The HADS demonstrates
strong construct validity and is sensitive to a counseling
intervention [44,45]. Cancer-specific fatigue will be mea-
sured using the Functional Assessment of Cancer Therapy-
Fatigue (FACT–F) which is a widely used 13-item measure
with strong reliability and validity [45,46]. The Pain Disabil-
ity Index (PDI) [47] will be used to assess the extent to
which persistent pain interferes with an individual’s ability
to engage in activities of daily living [48]. Urological symp-
toms are assessed using the valid and reliable, 7-item Inter-
national Prostate Symptom Score (IPSS) [49,50]. Erectile
function is assessed using the 5-item International Index of
Erectile Function (IIEF) scale, a widely used, psychometric-
ally validated multi-dimensional self-report instrument
evaluating male sexual function [51,52].
Physical activity level will be measured at each time
point through the Community Health Activities Model
Program for Seniors (CHAMPS) questionnaire [53]. The
CHAMPS is a self-reported measure of physical activity,
comprising 41 activities evaluated according to the total
number of hours done during an average week that can
be translated into average weekly caloric expenditure.
Acute postoperative physical activity will also be object-
ively measured via accelerometer from postoperative
admission to the inpatient ward until the participant
returns to the ambulatory clinic for catheter removal (typ-
ically 1–2 weeks). The Actiwatch 2 (Philips Healthcare,
Respironics, PA, USA) is a light-weight accelerometer worn
as a wristwatch on the non-dominant arm that is water re-
sistant and can be worn during bathing. The Actiwatch 2
can reliably measure movement volume in three dimensions
and quantified using the unit of ‘activity counts’ (AC) over
multiple days [54-56]. ACs (in counts per minute; cpm)
will be captured and stratified into the following categories
for analysis: sedentary (0–99 cpm), light activity (100–
1951 cpm), and moderate-to-vigorous activity (>1951 cpm).
As reported by Lynch et al. [57], physical activity volume
will be analyzed using percentage of device-wearing time
(in minutes) spent in the various activity categories.
Treatment complications and length of stay data will
be extracted from medical records.
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Participant characteristics will be summarized using
descriptive statistics (mean, standard deviation, fre-
quency). The equivalence of groups at baseline in
terms of demographic and clinical variables will be
assessed using independent samples t-tests for con-
tinuous variables and chi-square tests for categorical
variables. We will report recruitment and attrition
rates per site with comparison between sites using the
chi-square test. Adherence to the PREHAB and PFMX
prescriptions will be compared across study sites using
independent samples t-tests. Estimates of efficacy
(Group and Time main effect, as well as Group x
Time interactions) will be analyzed using a repeated-
measure analysis of covariance (ANCOVA), controlling
for the baseline value of the outcome of interest and
study site. Frequency of perioperative complications
will be compared between the PREHAB and UC
groups using chi-square analysis and as per the
Clavien-Dindo classification system [58]. Length of
stay between the PREHAB and UC groups will be
compared using independent samples t-test.Discussion
The primary outcome of this study is to determine the
feasibility of conducting a full-scale randomized controlled
trial of PREHAB versus UC and to determine estimates of
effect size to inform sample size for subsequent trials in
this field. To our knowledge, this is the first study to
examine a structured pre-surgical exercise program for
men undergoing RP for PCa. This trial will advance our
understanding of strategies to efficiently and effectively
use the preoperative period to optimize postoperative
recovery.
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